FDA Inspection 1262040 — Changzhou SynTheAll Pharmaceutical Co., Ltd
The FDA completed an inspection of Changzhou SynTheAll Pharmaceutical Co., Ltd on March 7, 2025 in Changzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 7, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Changzhou (China)